Svetol®: Innovative New Fat-Burning Agent Promotes Significant Weight-Loss WITHOUT STIMULANTS
Innovative New Fat-Burning Agent Promotes Significant Weight-Loss WITHOUT STIMULANTS
Virtually every effective fat-burner tested to date has had one thing in common—STIMULANTS, and usually lots of them. Recently however, a new discovery has yielded a stimulant-free fat-burning compound that may in fact exceed the power of even some of the most potent stimulant based fat-burners on the market. A specialized highly bioactive, yet decaffeinated, extract of green coffee extract called Svetol® was subjected to a rigorous double-blind clinical trial to assess its weight-loss effi cacy and impact on lean body mass. The results were truly extraordinary and in fact even exceed those achieved with many high stimulant compounds.
Thirty patients were administered 200 mg capsules of Svetol® per day, while 20 others received a placebo. After 60 days of treatment, a mean reduction in weight loss of 5.7% was observed in the Svetol® group. Such a reduction in body weight over just an 8 week period is quite remarkable. The Svetol® group also showed an increase in lean-to-fat-mass ratio of 4% as against only 1.5% in the placebo group, again indicating extraordinary potential.
Researchers theorize that Svetol® works by inhibiting the activity of glucose-6-phosphatase, which limits the release of glucose into general circulation and thus encourages the release of triglycerides from adipose tissue for consequential energy expenditure.
Svetol® was developed in France by a large nutriceutical company and is just now hitting the market here in the U.S. in an innovative new product by ProSource called DopaLean-GH. This exciting new product combines the clinically validated weight-loss action of Svetol® with an ultra-powerful GH support compound and contains no caffeine or stimulants.
Scientific Reference:
Svetol®, green coffee extract, induces weight-loss and increases the lean to fat mass ratio in volunteers with overweight problem. Dellalibera, SSA, et al. Department of Medicine and Obesity, Tortona, Italy.
Reposted from ProSource.net:
